DJIA 15,112.19 -206.04 -1.35%
NASDAQ 3,443.20 -38.98 -1.12%
S&P 500 1,628.93 -22.88 -1.39%
market minute promo

Medivation, Inc.

NASDAQ: MDVN

46.58 -2.17 (-4.45%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MDVN $46.58 -4.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.55
Previous Close $48.75
Daily Range $46.48 - $48.89
52-Week Range $41.52 - $59.24
Market Cap $3.5B
P/E Ratio -52.42
Dividend (Yield) $0.00 (0.0%)
Volume 781,089
Average Daily Volume 1,155,796
Current FY EPS -$1.03

Sector

Healthcare

Industry

Drugs

Medivation, Inc. (MDVN) Description

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies. Website: http://www.medivation.net/

News & Commentary Rss Feed

Why Medivation Shares Retreated

Is one company's gain another's pain?

Medivation's Competitor Was Just Acquired, But It's Not As Bad As It Sounds

Medivation's Xtandi Threatened By Johnson & Johnson's New Acquisition

J&J to Buy Aragon for $1 Billion - Analyst Blog

J&J to Buy Aragon for $1 Billion - Analyst Blog

Johnson & Johnson Gets Key Cancer Drug With Aragon Buy

Johnson & Johnson And Aragon May Have Medivation Feeling Sick

Afternoon Market Losers

J.P. Morgan Reiterates Overweight Rating on Medivation Following Aragon Pharmaceuticals Acquisition

J.P. Morgan Reiterates Overweight Rating on Medivation Following Aragon Pharmaceuticals Acquisition Announcement

Medivation Stock Falls On Unusually High Volume (MDVN)

Medivation, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 04:

Medivation, Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 04:00 PM

See More MDVN News...

MDVN's Top Competitors

MDVN $46.58 (-4.45%)
Current stock: MDVN
LIFE $74.21 (-0.08%)
Current stock: LIFE
TMO $84.69 (-1.73%)
Current stock: TMO
WAT $100.22 (-1.65%)
Current stock: WAT